In this issue:
Comparison of atezolizumab and nivolumab
JASPER: niraparib plus pembrolizumab
Cochrane review: targeted therapy for ALK-rearranged NSCLC
Smoking history: a predictor of checkpoint inhibitor efficacy?
ADAURA: HRQOL with adjuvant osimertinib
Discussion of advanced care planning on end of life
Postoperative home-based rehabilitation
Overdiagnosis in lung cancer screening
Hospital-based MDT care in Australia
Biomarker for diagnosis of lung cancer
Please login below to download this issue (PDF)